Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase

Clinical and Experimental Metastasis

Volumn 17, Issue 6, 1999, Pages 507-514

  Nakanishi, Katsuya ^a   Fujimoto, Jiro ^a   Ueki, Takahiro ^a   Kishimoto, Keigo ^a   Hashimoto Tamaoki, Tomoko ^a   Furuyama, Jun Ichi ^a   Itoh, Toshifumi ^b   Sasaki, Yutaka ^b   Okamoto, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

c Met; Hepatocyte growth factor; Motility; Phosphatidylinositol 3 kinase; Tyrosine phosphorylation

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR;

ARTICLE; CELL MIGRATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL CARCINOMA; METASTASIS; MUTAGENESIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL MOVEMENT; ENZYME INDUCTION; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENISTEIN; HEPATOCYTE GROWTH FACTOR; HUMANS; ISOENZYMES; NAPHTHALENES; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0033504024     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006685218766     Document Type: Article

References (36)

1. 1. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293-5.
2. 2. Shiota G, Wang TC, Nakamura T et al. Hepatocyte growth factor in transgenic mice: effect on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994; 19: 962-72.
3. 3. Gherardi E, Stoker M, Perryman M et al. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 1989; 86: 5844-8.
4. 4. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986; 83: 6489-93.
5. 5. Montesano R, Schaller G, Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991; 66: 697-711.
6. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994; 269: 31807-13.
7. 7. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600.
8. 8. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
9. 9. Di Renzo MF, Narsimhan RP, Olivero M et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991; 6: 1997-2003.
10. 10. Gonzatti-Haces M, Seth A, Park M et al. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein tyrosine kinase. Proc Natl Acad Sci USA 1989; 85: 21-5.
11. 11. Pawson T. Protein modules and signaling networks. Nature 1995; 373: 573-80.
12. 12. Zhu H, Naujokas MA, Fixman ED et al. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signal for cell motility and morphogenesis. J Biol Chem 1994; 269: 29943-48.
13. 13. Ponzetto C, Bardelli A, Zhen Z et al. A multifunctional docking site mediates signaling and transduction by the hepatocyte growth factor/Scatter factor receptor family. Cell 1994; 77: 261-71.
14. 14. Rodrigues GA, Park M. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Oncogene 1994; 9: 2019-27.
15. 15. Royal I, Park M. Hepatocyte growth factor-induced scatter of madindarby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem 1995; 270: 27780-7.
16. 16. Okuda K, Ohtsuki T, Obata H. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
17. 17. Suzuki K, Hayashi N, Yamada Y et al. Expression of the c-met protooncogene in human hepatocellular carcinoma. Hepatology 1994; 20: 1231-6.
18. 18. Ueki T, Fujimoto J, Suzuki T et al. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology 1997; 25: 619-23.
19. 19. Akiyama T, Ishida J, Nakagawa S et al. Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem 1987; 262: 5592-5.
20. 20. Yano H, Nakanishi S, Kimura K et al. Inhibition of histamine secretion by wortmannin through the blockage of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 1993; 268: 25856-64.
21. 21. Kobayashi E, Nakano H, Morimoto M et al. Calphostin C (UCN-1028 C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159: 548-53.
22. 22. Sunitha I, Meighen DL, Hartman DP et al. Hepatocyte growth factor stimulates invasion across reconstituted basement membrens by a new human small intestinal cell line. Clin Exp Metastasis 1994; 12: 143-54.
23. 23. Susa M, Keeler M, Varticovski L. Platelet-derived growth factor activates membrane-associated phosphatidylinositol 3-kinase and mediates its translocation from the cytosol. J Biol Chem 1992; 267: 22951-6.
24. 24. Guguen-Guillouzo C, Campion JP, Brissot P et al. High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep 1982; 6: 625-8.
25. 25. Tajima H, Matsumoto K, Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett 1991; 291: 229-32.
26. 26. Shiota G, Rhoads DB, Wang TC et al. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992; 89: 373-7.
27. 27. Santoni-Rugiu E, Preisegger KH, Kiss A et al. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 1996; 93: 9577-82.
28. 28. Takayama H, La Rochelle WJ, Sharp R et al. Diverse tumorgenesis associated with aberrant development in mice over-expressing hepatocyte growth factor/ scatter factor. Proc Natl Acad Sci USA 1997; 94: 701-6.
29. 29. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med 1999; 5: 226-30.
30. 30. Pawson T, Schlessinger J. SH2 and SH3 domeins. Curr Biol 1993; 3: 434-42.
31. 31. Egan SE, Weinberg RA. The pathway to signal achievement. Nature 1993; 365: 781-2.
32. 32. Stolz DB, Michalopoulos GK. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes. J Cell Biochem 1994; 55: 445-64.
33. 33. Adachi T, Nakashima S, Saji S et al. Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated hepatocytes: Involvement of protein tyrosine kinase and protein kinase C. Hepatology 1996; 23: 1244-53.
34. 34. Hartman G, Weidner KM, Schwarz H et al. The motility signal of scatter factor/ hepatocyte growth factor mediated through the receptor tyrosine kinase Met requires intracellular action of Ras. J Biol Chem 1994; 269: 21936-9.
35. 35. Ilic D, Furuta Y, Kanazawa S et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539-44.
36. 36. Amano M, Chihara K, Kimura K et al. Formation of actin stress fibers and focal adhesions enhancedby Rho-kinase. Science 1997; 275: 1308-11.